Lexogen is the Gold Sponsor of the online RNA Society Meeting 2020
Due to the rapid spread of COVID-19, the RNA Society will not hold its annual meeting in Vancouver as planned but has organized to move it online to maintain this
Due to the rapid spread of COVID-19, the RNA Society will not hold its annual meeting in Vancouver as planned but has organized to move it online to maintain this
Vienna, Austria, April 29, 2020 – Lexogen GmbH, a Vienna based Next-Generation Sequencing (NGS) and transcriptomics company, receives funding from the Austria Research Promotion Agency (FFG) for the development of

VIENNA, AUSTRIA, MARCH 24, 2020 – Lexogen is pleased to announce the appointment of Intra Globus Biosystems Pvt. Ltd (IGB) as its official distributor in India, as a further step

RNA extracted from bacterial species comprises up to 98 % of ribosomal RNAs (rRNA), preventing the in-depth analysis of RNAs of interest, particularly in the context of Next Generation Sequencing

Vienna, Austria, January 10, 2020 /PRNewswire/ – The massive output of modern short-read next generation sequencing (NGS) platforms allows to multiplex hundreds of samples to be processed in one NGS

QuantSeq is a 3’ mRNA-Seq library prep protocol, which is the method of choice for RNA-Seq gene expression analysis due to the simplicity, cost effectiveness, and data quality offered by
Analyzing how genes are expressed provides answers relevant for diagnostics, therapeutics and fundamental biology. The transcriptome, the entirety of a cell’s transcripts, is much more complex than the genome it
A typical RNA sequencing experiment assesses steady-state levels of the transcriptome by quantifying the total RNA content. This delivers a “snapshot” of the transcriptomic state of a cell at a

VIENNA, April 5, 2018 /PRNewswire/ — Identifying molecules that selectively modulate gene expression is highly desirable in drug development. However, standard RNA sequencing technologies and current metabolic RNA labeling methods

Press release Lexogen launches the SLAMseq product family for high throughput metabolic sequencing of RNA, developed in collaboration with the Institute of Molecular Biotechnology in Vienna, Austria. Dr. Stefan Ameres
Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna, Austria
Telephone:
+43 (0) 1 345 1212
Sales support:
+43 (0) 1 345 1212-42
Technical support:
+43 (0) 1 345 1212-41
Working hours: 9:00 – 17:00 (CET)
Fax: +43 (0) 1 345 1212-99
Email: info@lexogen.com
Company number: FN 297318 h
VAT number: ATU63622048
Lexogen, Inc.
51 Autumn Pond Park
Greenland, NH 03840, US
Telephone:
+1-603-431-4300 ext.0
+1-877-Lexogen
(+1-877-539-6436) ext. 0
Sales inquiries:
Northeast: +1-312-978-6413
Southeast: +1-615-968-3325
Northwest: +1-415-726-4318
Southwest: +1-520-934-0678
Technical support:
+1-949-767-1631
(Working hours: 9:00 – 17:00 (EST))
+1-603-498-1666
(Working hours: 7:30 – 15:30 (CST))
Fax: +1-603-431-4333
Lexogen Newsletter
Subscribe to our mailing list to be among the first to get updates from us!
Copyright © 2026 Lexogen GmbH. All rights reserved | Impressum | Privacy Policy | Terms and Conditions | Whistleblowing
Please choose which cookies you'd like to use.
Required
These cookies are required to provide core site functionality. These can't be disabled.
Analytics
These cookies allow us to analyse usage of our site so we can improve its performance.
Marketing
These cookies are used by advertisers to show you ads relevant to your interests.

Product Short Description
PRICE

Product Short Description
PRICE

Product Short Description
PRICE